Login/Register
  • 中文
  • English

News

Lotus Obtains Tentative Approval for Nintedanib ANDA from the US FDA

FDA has granted a tentative approval for the Company's Abbreviated New Drug Application (ANDA) for Nintedanib Capsules, the generic version of Boehringer Ingelheim’s OFEV®.

Read more
Jan 17, 2023
Formosa Biomedical joins hands with partners to develop cell therapy
Commercial Times
Jan 16, 2023
ITRI and China Medical University Hospital signed MOU for robotic solutions
DIGITIMES
Jan 16, 2023
Foresee Pharmaceuticals moved to NBRP to expand R&D capacity
Commercial Times
Jan 16, 2023
Caliway Biopharmaceuticals to conduct phase II trial for CBL-514 treating Dercum's disease
Economic Daily
Jan 13, 2023
WiAdvance in partnership with Oracle to create FHIR solution
DIGITIMES
Jan 13, 2023
PharmaEssentia establishes a new research and development facility in the Boston area
PharmaEssentia
Jan 12, 2023
Fu Jen Catholic Hospital now the 8th district hospital in new Taipei city, planning on its branch
CNEWS
Jan 12, 2023
Prenetics Owned ACT Genomics Receives FDA Clearance for ACTOnco, the First Asia-Based Company to Receive Clearance for a Comprehensive Genomic Profiling Test for All Solid Tumors
ACT Genomics
Jan 12, 2023
Mayo Clinic Florida visits Taipei Veterans General Hospital for co-op in particle radiotherapy
Liberty Times

Most Watched

Recommended

BriteMED® 12-Lead Portable ECG
BriteMED Technology Inc.
MED-PJ-8320 UHD+ 3x2 Matix with PiP
Cypress Technology Co.,Ltd.
Revio™ Long-Read Sequencing System
Blossom Biotechnologies

Industry Watch

Read more